Previous close | 24.99 |
Open | 26.16 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's range | 26.16 - 26.34 |
52-week range | 25.10 - 34.47 |
Volume | |
Avg. volume | 318 |
Market cap | 2.758B |
Beta (5Y monthly) | 1.04 |
PE ratio (TTM) | 0.15 |
EPS (TTM) | 1.71 |
Earnings date | 28 Aug 2024 - 02 Sept 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Patterson Companies (PDCO) unit and Pearl collaborate to bring advanced AI disease detection technology, Second Opinion, to Canada's dental practices, enhancing clinical performance and patient communication
LOS ANGELES, July 18, 2024--Pearl, the global leader in dental AI solutions, and Patterson Dental Canada, Inc., a subsidiary of Patterson Companies, Inc. (Nasdaq: PDCO), today announced a collaboration to expand access to Pearl’s Second Opinion® AI disease detection capabilities within the Canadian dental market.
Patterson Companies' (PDCO) latest integration features are likely to provide customers with additional options to streamline their experience.